Medium-Term Management Plan
The Company's medium- to long-term management strategies
Pipeline and Intellectual Property
Pipeline status of the Company's subsidiary, ASKA Pharmaceutical
Business Risks
Matters related to business conditions and accounting conditions that may have a significant impact on investors' decisions.
Disclosure policy
Our Disclosure policy to provide timely and appropriate information
IR Basic Policy
Our IR basic policy is posted here.
Disclaimer
Disclaimer regarding this website.